|
1
|
Noteborn MH, de Boer GF, van Roozelaar DJ,
Karreman C, Kranenburg O, Vos JG, Jeurissen SH, Hoeben RC, Zantema
A and Koch G: Characterization of cloned chicken anemia virus DNA
that contains all elements for the infectious replication cycle. J
Virol. 65:3131–3139. 1991.PubMed/NCBI
|
|
2
|
Danen-Van Oorschot AA, Fischer DF,
Grimbergen JM, Klein B, Zhuang S, Falkenburg JH, Backendorf C, Quax
PH, Van der Eb AJ and Noteborn MH: Apoptin induces apoptosis in
human transformed and malignant cells but not in normal cells. Proc
Natl Acad Sci USA. 94:5843–5847. 1997.
|
|
3
|
Rohn JL, Zhang YH, Aalbers RI, Otto N, Den
Hertog J, Henriquez NV, Van De Velde CJ, Kuppen PJ, Mumberg D,
Donner P and Noteborn MH: A tumor-specific kinase activity
regulates the viral death protein apoptin. J Biol Chem.
277:50820–50827. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Teodoro JG, Heilman DW, Parker AE and
Green MR: The viral protein apoptin associates with the
anaphase-promoting complex to induce G2/M arrest and apoptosis in
the absence of p53. Gene Dev. 18:1952–1957. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Danen-Van Oorschot AA, Zhang YH, Leliveld
SR, Rohn JL, Seelen MC, Bolk MW, Van Zon A, Erkeland SJ, Abrahams
JP, Mumberg D and Noteborn MH: Importance of nuclear localization
of apoptin for tumor-specific induction of apoptosis. J Biol Chem.
278:27729–27736. 2003.PubMed/NCBI
|
|
6
|
Sun GJ, Tong X, Dong Y, Mei ZZ and Sun ZX:
Identification of a protein interacting with apoptin from human
leucocyte cDNA library by using yeast two-hybrid screening. Sheng
Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao. 34:369–372. 2002.(In
Chinese).
|
|
7
|
Janssen K, Hofmann TG, Jans DA, Hay RT,
Schulze-Osthoff K and Fischer U: Apoptin is modified by SUMO
conjugation and targeted to promyelocytic leukemia protein nuclear
bodies. Oncogene. 26:1557–1566. 2007.PubMed/NCBI
|
|
8
|
Teodoro JG, Heilman DW, Parker AE and
Green MR: The viral protein apoptin associates with the
anaphase-promoting complex to induce G2/M arrest and apoptosis in
the absence of p53. Gene Dev. 18:1952–1957. 2004.PubMed/NCBI
|
|
9
|
Danen-van Oorschot AA, Voskamp P, Seelen
MC, van Miltenburg MH, Bolk MW, Tait SW, Boesen-de Cock JG, Rohn
JL, Borst J and Noteborn MH: Human death effector domain-associated
factor interacts with the viral apoptosis agonist apoptin and
exerts tumor-preferential cell killing. Cell Death Differ.
11:564–573. 2004.
|
|
10
|
Liu X, Elojeimy S, El-Zawahry AM, Holman
DH, Bielawska A, Bielawski J, Rubinchik S, Guo GW, Dong JY, Keane
T, Hannun YA, Tavassoli M and Norris JS: Modulation of ceramide
metabolism enhances viral protein apoptin’s cytotoxicity in
prostate cancer. Mol Ther. 14:637–646. 2006.PubMed/NCBI
|
|
11
|
Poon IK, Oro C, Dias MM, Zhang J and Jans
DA: Apoptin nuclear accumulation is modulated by a CRM1-recognized
nuclear export signal that is active in normal but not in tumor
cells. Cancer Res. 65:7059–7064. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huo DH, Yi LN and Yang J: Interaction with
Ppil3 leads to the cytoplasmic localization of apoptin in tumor
cells. Biochem Biophys Res Commun. 372:14–18. 2008. View Article : Google Scholar
|
|
13
|
Maddika S, Wiechec E, Ande SR, Poon IK,
Fischer U, Wesselborg S, Jans DA, Schulze-Osthoff K and Los M:
Interaction with PI3-kinase contributes to the cytotoxic activity
of apoptin. Oncogene. 27:3060–3065. 2008. View Article : Google Scholar
|
|
14
|
Maddika S, Bay GH, Kroczak TJ, Ande SR,
Maddika S, Wiechec E, Gibson SB and Los M: Akt is transferred to
the nucleus of cells treated with apoptin, and it participates in
apoptin-induced cell death. Cell Prolif. 40:835–848. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Maddika S, Panigrahi S, Wiechec E,
Wesselborg S, Fischer U, Schulze-Osthoff K and Los M: Unscheduled
Akt-triggered activation of CDK2 as a key effector mechanism of
apoptin’s anticancer toxicity. Mol Cell Biol. 29:1235–1248.
2009.PubMed/NCBI
|
|
16
|
Wadhwa R, Kaul SC, Ikawa Y and Sugimoto Y:
Identification of a novel member of mouse hsp70 family. Its
association with cellular mortal phenotype. J Biol Chem.
268:6615–6621. 1993.PubMed/NCBI
|
|
17
|
Singh B, Soltys BJ, Wu ZC, Patel HV,
Freeman KB and Gupta RS: Cloning and some novel characteristics of
mitochondrial Hsp70 from Chinese hamster cells. Exp Cell Res.
234:205–216. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ran Q, Wadhwa R, Kawai R, Kaul SC, Sifers
RN, Bick RJ, Smith JR and Pereira-Smith OM: Extramitochondrial
localization of mortalin/mthsp70/PBP74/GRP75. Biochem Biophys Res
Commun. 275:174–179. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Craig EA, Kramer J, Shilling J,
Werner-Washburne M, Holmes S, Kosic-Smithers J and Nicolet CM:
SSC1, an essential member of the yeast HSP70 multigene family,
encodes a mitochondrial protein. Mol Cell Biol. 9:3000–3008.
1989.PubMed/NCBI
|
|
20
|
Kaul SC, Taira K, Pereira-Smith OM and
Wadhwa R: Mortalin: present and prospective. Exp Gerontol.
37:1157–1164. 2002.PubMed/NCBI
|
|
21
|
Merrick BA, Walker VR, He C, Patterson RM
and Selkirk JK: Induction of novel Grp75 isoforms by 2-deoxyglucose
in human and murine fibroblasts. Cancer Lett. 119:185–190. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wadhwa R, Taira K and Kaul SC: Mortalin: a
potential candidate for biotechnology and biomedicine. Histol
Histopathol. 17:1173–1177. 2002.PubMed/NCBI
|
|
23
|
Wadhwa R, Takano S, Kaur K, Deocaris CC,
Pereira-Smith OM, Reddel RR and Kaul SC: Upregulation of
mortalin/mthsp70/Grp75 contributes to human carcinogenesis. Int J
Cancer. 118:2973–2980. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Peng DJ, Sun J, Wang YZ, Tian J, Zhang YH,
Noteborn MH and Qu S: Inhibition of hepatocarcinoma by systemic
delivery of apoptin gene via the hepatic asialoglycoprotein
receptor. Cancer Gene Ther. 14:66–73. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Drewes G, Ebneth A, Preuss U, Mandelkow EM
and Mandelkow E: MARK, a novel family of protein kinases that
phosphorylate microtubule-associated proteins and trigger
microtubule disruption. Cell. 89:297–308. 1997. View Article : Google Scholar
|
|
26
|
Rohn JL, Zhang YH, Aalbers RI, Otto N, Den
Hertog J, Henriquez NV, Van De Velde CJ, Kuppen PJ, Mumberg D,
Donner P and Noteborn MH: A tumor-specific kinase activity
regulates the viral death protein apoptin. J Biol Chem.
227:50820–50827. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ohtsuka R, Abe Y, Fujii T, Yamamoto M,
Nishimura J, Takayanagi R and Muta K: Mortalin is a novel mediator
of erythropoietin signaling. Eur J Haematol. 79:114–125. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bhattacharyya T, Karnezis AN, Murphy SP,
Hoang T, Freeman BC, Phillips B and Morimoto RI: Cloning and
subcellular localization of human mitochondrial hsp70. J Biol Chem.
270:1705–1710. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Koehler CM: New developments in
mitochondrial assembly. Annu Rev Cell Dev Biol. 20:309–335. 2004.
View Article : Google Scholar
|
|
30
|
Rehling P, Brandner and Pfanner N:
Mitochondrial import and the twin-pore translocase. Nat Rev Mol
Cell Biol. 5:519–530. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wiedemann N, Frazier AE and Pfanner N: The
protein import machinery of mitochondria. J Biol Chem.
279:14473–14476. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Craig EA, Kramer J and Kosic-Smithers J:
SSC1, a member of the 70-kDa heat shock protein multigene family of
Saccharomyces cerevisiae, is essential for growth. Proc Natl
Acad Sci USA. 84:4156–4160. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kawai A, Nishikawa S, Hirata A and Endo T:
Loss of the mitochondrial Hsp70 functions causes aggregation of
mitochondria in yeast cells. J Cell Sci. 114:3565–3574.
2001.PubMed/NCBI
|
|
34
|
Kaul SC, Deocaris CC and Wadhwa R: Three
faces of mortalin: a housekeeper, guardian and killer. Exp
Gerontol. 42:263–274. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Maddika S, Booy EP, Johar D, Gibson SB,
Ghavami S and Los M: Cancer-specific toxicity of apoptin is
independent of death receptors but involves the loss of
mitochondrial membrane potential and the release of mitochondrial
cell-death mediators by a Nur77-dependent pathway. J Cell Sci.
118:4485–4493. 2005. View Article : Google Scholar
|
